# NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS england](/buyers/nhs-england/contract-awards)
- Contract winner: Janssen-Cilag Ltd
- Award value: £27,009,807
- Tender value: £27,009,807
- Award date: 28 March 2023
- Published: 27 April 2023
- Contract start: 1 May 2023
- Contract end: 31 January 2025
- Stage: awarded
- Procurement category: goods
- Notice ID: 101ad108-6a5b-410d-b375-4ca49a187c9e-640340
- OCID: ocds-b5fd17-c5f1ad7d-fcac-4ac7-bdd9-f6fe1f150616

## Description

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER \(FTS\) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 48 months\. Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 - 30/04/2024 - \(12 Months\) LSNE 01/05/2023 - 30/04/2024 - \(12 Months\) NWLN 01/05/2023 - 30/04/2024 - \(12 Months\) CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 - 31/05/2024 \(13 Months\) NWLN 01/05/2023 - 31/01/2025 \(21 months\)

## Related contract awards

- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England
- [D&A Platform Run & Maintain](/contracts/ocds-b5fd17-58fe109d-49a3-4eea-957d-31f6bd69ff81): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/101ad108-6a5b-410d-b375-4ca49a187c9e-640340)